Cognitive
Edaravone
Free-radical scavenger approved for ALS and studied for neuroprotection.
- Third-party tested
- EU shipping · discreet delivery, free over €459.99
- Card, Apple Pay, Google Pay or crypto
Overview
Edaravone neutralises free radicals that damage nerve cells. It was first approved in Japan for acute stroke and later for amyotrophic lateral sclerosis (ALS) in several countries.
It is studied for its ability to slow nerve cell damage caused by oxidative stress.
Research areas
- Oxidative damage to nerve cells
- ALS and motor neuron disease
- Stroke models
Specifications
- Category
- Cognitive
- Compound
- Small molecule, free-radical scavenger
- Structure
- Not a peptide
- Form
- Powder
- Available as
- 5000mg (Ultra-Pure Powder)
- Quality
- Third-party tested
Storage and handling
Store sealed in a cool, dry place, away from light and moisture. Freezer storage (−20 °C) extends shelf life.
Sold strictly for laboratory research use only. Not for human consumption, and not intended to diagnose, treat, cure or prevent any disease.